title: A study of the effects of ipriflavone administration on hemodialysis patients with renal osteodystrophy: preliminary report.
authors.forename: T
authors.initials: T
authors.lastname: Hyodo
authors.forename: K
authors.initials: K
authors.lastname: Ono
authors.forename: T
authors.initials: T
authors.lastname: Koumi
authors.forename: I
authors.initials: I
authors.lastname: Miyagawa
authors.forename: T
authors.initials: T
authors.lastname: Okano
authors.forename: T
authors.initials: T
authors.lastname: Kagawa
authors.forename: H
authors.initials: H
authors.lastname: Hagino
authors.forename: H
authors.initials: H
authors.lastname: Kishimoto
authors.forename: Y
authors.initials: Y
authors.lastname: Oyama
authors.forename: A
authors.initials: A
authors.lastname: Inoue
mesh_terms: D000469:Alkaline Phosphatase / Q000097:blood; D002116:Calcitonin / Q000097:blood; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000188:drug therapy*; D006801:Humans; D007529:Isoflavones / Q000627:therapeutic use*; D015675:Osteocalcin / Q000097:blood; D006435:Renal Dialysis
chemical_list: D007529:Isoflavones; D015675:Osteocalcin; C018986:ipriflavone; D002116:Calcitonin; D000469:Alkaline Phosphatase